Plasma glucose regulation and mortality in Pima Indians

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 488-492

  Kim, Nan Hee ^a,c   Pavkov, Meda E ^a   Looker, Helen C ^b   Nelson, Robert G ^a   Bennett, Peter H ^a   Hanson, Robert L ^a   Curtis, Jeffrey M ^a   Sievers, Maurice L ^a   Knowler, William C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK ASSESSMENT; AGE; AMERICAN INDIAN; BLOOD; ETHNOLOGY; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES;

ADULT; AGE FACTORS; ARIZONA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEX FACTORS; SURVIVAL RATE;

EID: 44449167710     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1850     Document Type: Article

References (22)

1. DECODE Study group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
2. Balkau B, Shipley M, Jarrett RJ, et al.: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360-367, 1998
3. Balkau B, Bertrais S, Ducimetiere P, et al.: Is there a glycemic threshold for mortality risk? Diabetes Care 22:696-699, 1999
4. Qiao Q, Pyorala K, Pyorala M, et al.: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23:1267-1275, 2002
5. Pankow JS, Kwan DK, Duncan BB, et al.: Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care 30:325-331, 2007
6. De Vegt F, Dekker JM, Ruhe HG, et al.: Hyperglycemia is associated with allcause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931, 1999
7. Stern MP, Fatehi P, Williams K, et al.: Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 25:1851-1856, 2002
8. Rijkelijkhuizen JM, Nijpels G, Heine RJ, et al.: High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn Study. Diabetes Care 30: 332-336, 2007
9. Qiao Q, Jousilahti P, Eriksson J, et al.: Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26:2910-2914, 2003
10. Pavkov ME, Sievers ML, Knowler WC, et al.: An explanation for the increase in heart disease mortality rates in diabetic Pima Indians: effect of renal replacement therapy. Diabetes Care 27:1132-1136, 2004
11. Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
12. Jimenez-Corona A, Nelson RG, Sievers ML, et al.: Electrocardiographic abnormalities predict deaths from cardiovascular disease and ischemic heart disease in Pima Indians with type 2 diabetes. Am Heart J 151:1080-1086, 2006
13. Diggle PJ, Liang KY, Zeger SL: Generalized models for longitudinal data. In Analysis of Longitudinal Data. Diggle PJ, Liang KY, Zeger SL, Eds. Oxford, Oxford University Press, 1994, p. 131-145
14. Knowler WC, Bennett PH, Hamman RF, et al. : Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
15. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 419-448, 1959
16. Mantel N: Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc 59: 690-700, 1963
17. Rothman KJ, Boice JD: Epidemiologic Analysis With a Programmable Calculator: National Institutes of Health. Washington, DC, U.S. Govt. Printing Office, 1979 (NIH publ. no. NIH 79-1949)
18. Gabir MM, Hanson RL, Dabelea D, et al.: Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113-1118, 2000
19. Levitan EB, Song Y, Ford ES, et al.: Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164: 2147-2155, 2004
20. Nelson RG, Sievers ML, Knowler WC, et al.: : Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990
21. Collier A, Matthews DM, Young RJ, et al.: Transient atrial fibrillation precipitated by hypoglycaemia: two case reports. PostgradMed J 63:895-897, 1978
22. Duh E, Feinglos M: Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med 121: 945-946, 1994